Massimo Alfano, PhD discusses a novel platform for bladder tumor imaging.
Join Dr. Massimo Alfano from San Raffaele University for the fourth episode of the Vevo 4 Oncology Web Series. There is a need within health programs for diagnostic imaging and eradication of small, chemo-resistant neoplastic lesions. In this webinar, Dr. Alfano discusses a novel technological platform for early detection of neoplastic modifications and early treatment of solid cancers, including bladder neoplasia. Those from any education or experience level are welcome to join to learn more about contrast-enhanced bladder tumor imaging.
Key Topics Include:
- Health programs crave for diagnostic imaging and eradication of chemo resistant neoplastic lesions smaller than 1 mm of size.
- Novel technological platform for the early detection of neoplastic modifications and early treatment of solid cancers. Proof of concept in preclinical models of bladder cancer.
- Advanced transformative technology, integrating the use of targeted gold nano-rods, high-resolution sonography and photoacoustic imaging in a unique and novel platform for the 3D visualization of bladder neoplasia < 0.5 mm.
Presenters
Group Leader, Extracellular Microenvironment Unit
Urological Research Institute
DiBit2, Scientific Institute San Raffaele
Massimo Alfano is a biologist with experience in the field of preclinical and translational research. He has developed extensive scientific expertise and gained managerial skills allowing him to interact with national and international granting agencies, as well as with multi- and inter-disciplinary scientists to design integrated approaches to different diseases, including both non-oncology and oncology fields.
Webinar Host
FUJIFILM VisualSonics Inc.
FUJIFILM VisualSonics designs and manufactures ultra high frequency in vivo imaging systems, for both research and clinical use. our ultrasound platform provides images at resolutions that far exceed any other system available on the market. Beyond ultrasound, we have also developed a unique photoacoustic technology to expand on the capabilities of our imaging solutions.
Additional Content From FUJIFILM VisualSonics Inc.
The Translational Utility of Ultrasound and Photoacoustics in Head and Neck Oncology
Dr. Mukund Seshadri will present their interdisciplinary research on developing and evaluating ultrasound and photoacoustic imaging for oral oncology applications, with a focus on the prognostic utility of these methods in assessing treatment responses in head and neck cancer patients.
Photoacoustic Imaging in Angiotensin II Induced Cardiac Hypertrophy Mice
Hear Dr. Emily Lupton on her lab's investigation whether photoacoustic imaging (PAI) could provide novel imaging in the heart after angiotensin-II induced hypertrophy with and without treatment with losartan.
Superpixel Unmixing Algorithm from Micro to Macro Photoacoustic Imaging of Tissue Components
Dr. Valeria Grasso describes a novel unsupervised Machine-Learning method named Superpixel Photoacoustic Unmixing (SPAX) framework.
Related Content
Assessing Antigen-Specific T-Cell Functionality with Dendritic Cell/CD8⁺ T Cell Co-culture
In this webinar, learn how to set up DC and CD8⁺ T cell co-culture experiments and assess T cell proliferation and killing activity.
A Ready-to-Analyze High-Plex Spatial Signature Development Workflow for Cancer Immunotherapy
In this webinar, Aditya Pratapa and Lorcan Sherry present a new workflow for analyzing multiplex immunoflurescence images.
Overcome the Multiple Challenges of Neutralizing Antibodies in Cancer Therapy Using Innovative Phage Display Technologies
In this webinar, Dr. Conor McCartin discusses how phage display can be used for human antibody development.